DM
SRNE

Deerfield Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Deerfield Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,091,461
Closed -$5.58M – 107
2019
Q2 		$5.58M Buy
+2,091,461
New +$7.53M 0.2% 79

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deerfield Management's SRNE Position: Q3 2019 in Review

Deerfield Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2019, closing a stake of 2,091,461 shares — an estimated $5.58M sold.

Deerfield Management first reported a position in SRNE in Q2 2019 and held it in 1 quarter. The position peaked at $5.58M in Q2 2019. 85 funds tracked by Wall St. Rank hold SRNE as of Q3 2019.

  • Deerfield Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Deerfield Management sold 2,091,461 Sorrento Therapeutics, Inc. shares in Q3 2019, an estimated $5.58M.
  • Deerfield Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Deerfield Management's Sorrento Therapeutics, Inc. position peaked at $5.58M in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2019.

Based on Deerfield Management's 13F filing for Q3 2019, filed 14 Nov 2019.